Table 3. Univariate and Multivariate Analysis among Groups.
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p value | |
FLT vs. PTC | ||||||
TSH>2.50 µIU/mL | 4.462 | 2.169-9.178 | <0.001 | |||
Tg-Ab positivity | 9.118 | 4.191-19.841 | <0.001 | 3.036 | 1.060-8.696 | 0.039 |
TPO-Ab positivity | 4.136 | 2.010-8.514 | <0.001 | |||
Taller than wider | 0.815 | 0.421-1.576 | 0.543 | |||
Absence of calcification | 2.897 | 1.340-6.261 | 0.007 | 3.781 | 1.182-12.097 | 0.025 |
Presence of DTD pattern | 36.231 | 14.192-92.500 | <0.001 | 24.519 | 8.597-69.925 | <0.001 |
AH vs. PTC | ||||||
TSH>2.50 µIU/mL | 0.917 | 0.404-2.077 | 0.835 | |||
Tg-Ab positivity | 0.735 | 0.283-1.909 | 0.527 | |||
TPO-Ab positivity | 0.425 | 0.161-1.122 | 0.084 | 0.427 | 0.157-1.163 | 0.096 |
Taller than wider | 0.292 | 0.146-0.587 | 0.001 | 0.288 | 0.140-0.590 | 0.001 |
Absence of calcification | 0.700 | 0.367-1.336 | 0.280 | |||
Presence of DTD pattern | 1.145 | 0.386-3.395 | 0.808 |
FLT, focal lymphocytic thyroiditis; PTC, papillary thyroid cancer; AH, adenomatous hyperplasia; TSH, thyrotropin; Tg-Ab, thyroglobulin antibody; TPO-Ab, thyroid peroxidase antibody; DTD pattern, "diffuse thyroid disease" pattern on US; OR, odds ratio; CI, confidence interval; US, ultrasound.